Endometrial Cancer - LOHP Alone and With 5FU
NCT00612495
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
31
Enrollment
INDUSTRY
Sponsor class
Conditions
Endometrial Cancer
Interventions
DRUG:
oxaliplatin, 5 FU
Sponsor
Sanofi